{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:44:54Z","timestamp":1778618694107,"version":"3.51.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantationreviews.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.trre.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T18:15:55Z","timestamp":1502820955000},"page":"249-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The epigenetic promise to improve prognosis of heart failure and heart transplantation"],"prefix":"10.1016","volume":"31","author":[{"given":"Chiara","family":"Sabia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"Picascia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7949-7771","authenticated-orcid":false,"given":"Cristiano","family":"Amarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Maiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2017.08.004_bb0005","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.trre.2017.08.004_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.6002\/ect.2011.0185","article-title":"Current concepts in histocompatibility during heart transplant","volume":"10","author":"Picascia","year":"2012","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.trre.2017.08.004_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.2009.05096.x","article-title":"Epigenetics in heart failure","volume":"1188","author":"Papait","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.trre.2017.08.004_bb0020","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.111.085787","article-title":"Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms?","volume":"125","author":"Napoli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2017.08.004_bb0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00395-013-0361-1","article-title":"Epigenetics: a new mechanism of regulation of heart failure?","volume":"108","author":"Papait","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacc.2014.05.021","article-title":"Epigenetic memory and cardiac cell therapy","volume":"64","author":"Alvarez","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lfs.2014.08.003","article-title":"Epigenetics, the missing link in hypertension","volume":"129","author":"Raftopoulos","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.trre.2017.08.004_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvr201","article-title":"Maternal-foetal epigenetic interactions in the beginning of cardiovascular damage","volume":"92","author":"Napoli","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-biochem-052610-091920","article-title":"Programming of DNA methylation patterns","volume":"81","author":"Cedar","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.trre.2017.08.004_bb0050","article-title":"Physical and functional HAT\/HDAC interplay regulates protein acetylation balance","volume":"371832","author":"Peserico","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.trre.2017.08.004_bb0055","article-title":"MicroRNAs and cardiovascular diseases","volume":"682857","author":"Nishiguchi","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.trre.2017.08.004_bb0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates microRNA processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.trre.2017.08.004_bb0065","doi-asserted-by":"crossref","first-page":"12418","DOI":"10.1038\/ncomms12418","article-title":"DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy","volume":"7","author":"Greco","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.trre.2017.08.004_bb0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4330\/wjc.v8.i2.211","article-title":"Novel epigenetic-based therapies useful in cardiovascular medicine","volume":"8","author":"Napoli","year":"2016","journal-title":"World J Cardiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0075","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1210\/en.2014-1595","article-title":"Inhibiting DNA Methylation by 5-Aza-2\u2032-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation","volume":"155","author":"Cao","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.trre.2017.08.004_bb0080","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1172\/JCI74792","article-title":"Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis","volume":"124","author":"Dunn","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trre.2017.08.004_bb0085","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/ATVBAHA.113.301765","article-title":"Histone and DNA methylation-mediated epigenetic downregulation of endothelial Kruppel-like factor 2 by low-density lipoprotein cholesterol","volume":"33","author":"Kumar","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trre.2017.08.004_bb0090","doi-asserted-by":"crossref","first-page":"H189","DOI":"10.1152\/ajpheart.01218.2011","article-title":"Epigenetic upregulation of p66shc mediates low-density lipoprotein cholesterol-induced endothelial cell dysfunction","volume":"303","author":"Kim","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bcp.2014.11.013","article-title":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications","volume":"93","author":"Tikoo","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trre.2017.08.004_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.lfs.2014.10.010","article-title":"Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques","volume":"129","author":"Wierda","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.trre.2017.08.004_bb0105","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/ATVBAHA.113.302701","article-title":"MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice","volume":"34","author":"Du","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trre.2017.08.004_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/cvr\/cvp121","article-title":"MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte\/macrophages","volume":"83","author":"Chen","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1074248415591698","article-title":"Epigenetic therapy for the treatment of hypertension-induced cardiac hypertrophy and fibrosis","volume":"21","author":"Watson","year":"2016","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.trre.2017.08.004_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008564","article-title":"Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure","volume":"5","author":"Movassagh","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2017.08.004_bb0125","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1161\/CIRCULATIONAHA.111.040071","article-title":"Distinct epigenomic features in end-stage failing human hearts","volume":"124","author":"Movassagh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2017.08.004_bb0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/em.20596","article-title":"Differential methylation of CpG sites in two isoforms of myosin binding protein C, an important hypertrophic cardiomyopathy gene","volume":"52","author":"Meurs","year":"2011","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.trre.2017.08.004_bb0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/emmm.201201553","article-title":"Alterations in cardiac DNA methylation in human dilated cardiomyopathy","volume":"5","author":"Haas","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.trre.2017.08.004_bb0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ygeno.2016.07.001","article-title":"Methylome analysis reveals alterations in DNA methylation in the regulatory regions of left ventricle development genes in human dilated cardiomyopathy","volume":"108","author":"Jo","year":"2016","journal-title":"Genomics"},{"key":"10.1016\/j.trre.2017.08.004_bb0145","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1172\/JCI46277","article-title":"The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice","volume":"121","author":"Zhang","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trre.2017.08.004_bb0150","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/labinvest.2011.92","article-title":"Hydralazine induced promoter demethylation enhances sarcoplasmic reticulum Ca2+ \u2212ATPase and calcium homeostasis in cardiac myocytes","volume":"91","author":"Kao","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.trre.2017.08.004_bb0155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/1440-1681.12089","article-title":"Heart failure and angiotensin II modulate atrial Pitx2c promotor methylation","volume":"40","author":"Kao","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0160","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2014.06.010","article-title":"DNA methylation inhibition: a novel therapeutic strategy for heart failure","volume":"176","author":"Kao","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0165","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/jcmm.12901","article-title":"Epigenetic silencing of TIMP4 in heart failure","volume":"20","author":"Chaturvedi","year":"2016","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.trre.2017.08.004_bb0170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000438864","article-title":"Novel histone deacetylase inhibitor modulates cardiac peroxisome proliferator-activated receptors and inflammatory cytokines in heart failure","volume":"96","author":"Lkhagva","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.trre.2017.08.004_bb0175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-7-10","article-title":"HDAC class I inhibitor, mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation","volume":"7","author":"Nural-Guvener","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.trre.2017.08.004_bb0180","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1159\/000447853","article-title":"Cardiac-specific overexpression of miR-222 induces heart failure and inhibits autophagy in mice","volume":"39","author":"Su","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.trre.2017.08.004_bb0185","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/CIRCRESAHA.114.303784","article-title":"Loss of microRNA-155 protects the heart from pathological cardiac hypertrophy","volume":"114","author":"Seok","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jjcc.2013.05.017","article-title":"Potential benefits of cell therapy in coronary heart disease","volume":"62","author":"Grimaldi","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0195","doi-asserted-by":"crossref","first-page":"29147","DOI":"10.1074\/jbc.M403618200","article-title":"DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E","volume":"9","author":"Lund","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trre.2017.08.004_bb0200","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/01.CIR.0000127429.53391.78","article-title":"Attenuation of oxidative stress and remodeling by cardiac inhibitor of metalloproteinase protein transfer","volume":"109","author":"Cox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2017.08.004_bb0205","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCRESAHA.114.303634","article-title":"Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies postmyocardial infarction remodeling in mice","volume":"114","author":"Zavadzkas","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0210","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1152\/physiolgenomics.00013.2013","article-title":"Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis","volume":"45","author":"Koczor","year":"2013","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.trre.2017.08.004_bb0215","first-page":"1828","article-title":"The blood genome-wide DNA methylation analysis reveals novel epigenetic changes in human heart failure","volume":"21","author":"Li","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.trre.2017.08.004_bb0220","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gad.1563807","article-title":"Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility","volume":"21","author":"Montgomery","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.trre.2017.08.004_bb0225","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1172\/JCI35847","article-title":"Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice","volume":"118","author":"Montgomery","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trre.2017.08.004_bb0230","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2443.2008.01252.x","article-title":"Genome-wide histone methylation profile for heart failure","volume":"14","author":"Kaneda","year":"2009","journal-title":"Genes Cells"},{"key":"10.1016\/j.trre.2017.08.004_bb0235","doi-asserted-by":"crossref","first-page":"20164","DOI":"10.1073\/pnas.1315155110","article-title":"Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy","volume":"110","author":"Papait","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trre.2017.08.004_bb0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jjcc.2016.10.004","article-title":"Evidence of epigenetic tags in cardiac fibrosis","volume":"69","author":"Grimaldi","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0245","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1016\/j.ijcard.2013.07.111","article-title":"Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure","volume":"168","author":"Kao","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0250","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/ATVBAHA.114.303393","article-title":"Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development","volume":"34","author":"Cao","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trre.2017.08.004_bb0255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2016.11.204","article-title":"Treatment of cardiovascular pathology with epigenetically active agents: focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation","volume":"227","author":"Chistiakov","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1139\/cjpp-2016-0542","article-title":"Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy","volume":"95","author":"Raghunathan","year":"2017","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.trre.2017.08.004_bb0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1423-0127-21-57","article-title":"Downregulation of Sirt1 as aging change in advanced heart failure","volume":"21","author":"Lu","year":"2014","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.trre.2017.08.004_bb0270","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1242\/dmm.024513","article-title":"Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors","volume":"1","author":"Gal\u00e1n","year":"2016","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.trre.2017.08.004_bb0275","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","article-title":"A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure","volume":"103","author":"van Rooij","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trre.2017.08.004_bb0280","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.RES.0000257913.42552.23","article-title":"MicroRNAs play an essential role in the development of cardiac hypertrophy","volume":"100","author":"Sayed","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0285","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/cr.2011.132","article-title":"Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice","volume":"22","author":"Wang","year":"2012","journal-title":"Cell Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0290","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bbrc.2013.05.079","article-title":"MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2","volume":"436","author":"Yang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trre.2017.08.004_bb0295","article-title":"MiR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathways","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2017.08.004_bb0300","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1159\/000350117","article-title":"MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention","volume":"31","author":"Tu","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.trre.2017.08.004_bb0305","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCRESAHA.112.300682","article-title":"MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress","volume":"112","author":"Huang","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0310","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCRESAHA.116.303549","article-title":"Long noncoding RNAs and microRNAs in cardiovascular pathophysiology","volume":"116","author":"Thum","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0315","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jss.2014.06.044","article-title":"Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivo","volume":"192","author":"Yang","year":"2014","journal-title":"J Surg Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0320","doi-asserted-by":"crossref","first-page":"592512","DOI":"10.1155\/2015\/592512","article-title":"Differential regulation of microRNAs in end-stage failing hearts is associated with left ventricular assist device unloading","volume":"2015","author":"Barsanti","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.trre.2017.08.004_bb0325","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/eurjhf\/hfr155","article-title":"Serum levels of microRNAs in patients with heart failure","volume":"14","author":"Goren","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.trre.2017.08.004_bb0330","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.healun.2015.01.979","article-title":"Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy","volume":"34","author":"Miyamoto","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.004_bb0335","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","article-title":"Circulating microRNAs in patients with coronary artery disease","volume":"107","author":"Fichtlscherer","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0340","doi-asserted-by":"crossref","first-page":"985408","DOI":"10.1155\/2014\/985408","article-title":"MicroRNAs expression profiles in cardiovascular diseases","volume":"2014","author":"Bronze-da-Rocha","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.trre.2017.08.004_bb0345","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijcard.2016.09.010","article-title":"Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure","volume":"224","author":"Vegter","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trre.2017.08.004_bb0350","first-page":"2276","article-title":"MicroRNAs in heart failure: non-coding regulators of metabolic function","volume":"2016","author":"Zhang","year":"1862","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trre.2017.08.004_bb0355","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1432-2277.2011.01247.x","article-title":"Surgical wound complications after heart transplantation","volume":"24","author":"Zuckermann","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2017.08.004_bb0360","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s12265-014-9587-z","article-title":"Human leukocyte antigens and alloimmunization in heart transplantation: an open debate","volume":"7","author":"Picascia","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0365","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.trre.2016.07.007","article-title":"From HLA typing to anti-HLA antibody detection and beyond: the road ahead","volume":"30","author":"Picascia","year":"2016","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.trre.2017.08.004_bb0370","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tig.2012.06.005","article-title":"DNA methylation: a promising landscape for immune system-related diseases","volume":"28","author":"Suarez-Alvarez","year":"2012","journal-title":"Trends Genet"},{"key":"10.1016\/j.trre.2017.08.004_bb0375","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/imm.12074","article-title":"T-cell memory differentiation: insights from transcriptional signatures and epigenetics","volume":"139","author":"Youngblood","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.trre.2017.08.004_bb0380","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.tp.0000264997.53153.8b","article-title":"Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients","volume":"83","author":"Dijke","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.004_bb0385","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s10875-008-9249-5","article-title":"Regulation and privilege in transplantation tolerance","volume":"28","author":"Waldmann","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.trre.2017.08.004_bb0390","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.transproceed.2009.02.101","article-title":"Use of epigenetic modification to induce FOXP3 expression in naive T cells","volume":"41","author":"Moon","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2017.08.004_bb0395","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/MCB.05155-11","article-title":"Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp31 T-regulatory cells","volume":"31","author":"de Zoeten","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trre.2017.08.004_bb0400","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2002873","article-title":"Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms","volume":"5","author":"Beier","year":"2012","journal-title":"Sci Signal"},{"key":"10.1016\/j.trre.2017.08.004_bb0405","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/cmi.2012.28","article-title":"SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection","volume":"9","author":"Zhang","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.trre.2017.08.004_bb0410","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/TP.0b013e31829b7bfc","article-title":"SAHA, an HDAC inhibitor, attenuates antibody-mediated allograft rejection","volume":"96","author":"Zhang","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.004_bb0415","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1097\/TP.0000000000001197","article-title":"Modulation of donor-specific antibody production after organ transplantation by valproic acid: a histone deacetylase inhibitor","volume":"100","author":"Ye","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.004_bb0420","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1248\/bpb.31.1723","article-title":"Effect of a new immunosuppressant histon deacetylase (HDAC) inhibitor FR276457 in a rat cardiac transplant model","volume":"31","author":"Kinugasa","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.trre.2017.08.004_bb0425","first-page":"161","article-title":"Clinical relevance of curcumin-induced immunosuppression in living-related donor renal transplantation: an in vitro analysis","volume":"8","author":"Bharti","year":"2010","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.trre.2017.08.004_bb0430","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.trre.2017.08.004_bb0435","first-page":"424","article-title":"MicroRNAs involved in acute rejection and tolerance in murine cardiac allografts","volume":"14","author":"Fujino","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.trre.2017.08.004_bb0440","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/ajt.13421","article-title":"RNA profiling in human and murine transplanted hearts: identification and validation of therapeutic targets for acute cardiac and renal allograft rejection","volume":"16","author":"Van Aelst","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.004_bb0445","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.healun.2016.04.018","article-title":"Knockout of microRNA-155 ameliorates the Th1\/Th17 immune response and tissue injury in chronic rejection","volume":"36","author":"Zhang","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.004_bb0450","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/TP.0b013e318280b385","article-title":"miRNA profiling discriminates types of rejection and injury in human renal allografts","volume":"95","author":"Wilflingseder","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.004_bb0455","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/cvr\/cvw030","article-title":"miR-21 promotes fibrosis in an acute cardiac allograft transplantation model","volume":"110","author":"Gupta","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trre.2017.08.004_bb0460","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1093\/eurheartj\/ehu346","article-title":"MicroRNAs as non-invasive biomarkers of heart transplant rejection","volume":"35","author":"Duong Van Huyen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.trre.2017.08.004_bb0465","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000001477","article-title":"MicroRNA 628-5p as a novel biomarker for cardiac allograft vasculopathy","volume":"101","author":"Neumann","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.004_bb0470","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.healun.2015.06.008","article-title":"Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy","volume":"34","author":"Singh","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.004_bb0475","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12015-016-9711-3","article-title":"Possible muscle repair in the human cardiovascular system","volume":"13","author":"Sommese","year":"2017","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.trre.2017.08.004_bb0480","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/cpf.12210","article-title":"Imaging techniques to evaluate cell therapy in peripheral artery disease: state of the art and clinical trials","volume":"36","author":"Grimaldi","year":"2016","journal-title":"Clin Physiol Funct Imaging"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X17300174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X17300174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T10:20:36Z","timestamp":1535451636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X17300174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0955470X17300174"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2017.08.004","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epigenetic promise to improve prognosis of heart failure and heart transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}